Bluejay Diagnostics, Inc. (BJDX)
USD 3.54
(8.92%)
USD 3.54
(8.92%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.97 Million USD | -0.32% |
| 2022 | 1.97 Million USD | 210.75% |
| 2021 | 637.16 Thousand USD | -88.87% |
| 2020 | 5.72 Million USD | 48.7% |
| 2019 | 3.84 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.7 Million USD | -13.47% |
| 2024 Q2 | 2.21 Million USD | 29.88% |
| 2023 Q4 | 1.97 Million USD | -34.94% |
| 2023 FY | 1.97 Million USD | -0.32% |
| 2023 Q3 | 3.03 Million USD | 44.31% |
| 2023 Q2 | 2.1 Million USD | 21.85% |
| 2023 Q1 | 1.72 Million USD | -12.88% |
| 2022 Q3 | 1.89 Million USD | 34.4% |
| 2022 Q2 | 1.4 Million USD | -11.44% |
| 2022 Q1 | 1.59 Million USD | 149.82% |
| 2022 FY | 1.97 Million USD | 210.75% |
| 2022 Q4 | 1.97 Million USD | 4.5% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q2 | 3.24 Million USD | 0.0% |
| 2021 Q4 | 637.16 Thousand USD | -86.45% |
| 2021 Q3 | 4.7 Million USD | 44.77% |
| 2021 FY | 637.16 Thousand USD | -88.87% |
| 2020 Q4 | 5.72 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 5.72 Million USD | 48.7% |
| 2019 FY | 3.84 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 96.149% |
| BrainsWay Ltd. | 15.31 Million USD | 87.112% |
| Cerus Corporation | 144.3 Million USD | 98.632% |
| Envoy Medical, Inc. | 9.4 Million USD | 79.008% |
| electroCore, Inc. | 8.94 Million USD | 77.935% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 63.053% |
| IceCure Medical Ltd | 4.24 Million USD | 53.528% |
| Inogen, Inc. | 121.38 Million USD | 98.374% |
| OrthoPediatrics Corp. | 72.56 Million USD | 97.28% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 93.328% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 37.972% |
| MaxCyte, Inc. | 36.1 Million USD | 94.534% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -6.806% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -364.089% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.396% |
| PAVmed Inc | 57.13 Million USD | 96.546% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 92.249% |
| RxSight, Inc. | 22.18 Million USD | 91.105% |
| Sight Sciences, Inc. | 46.43 Million USD | 95.75% |
| SI-BONE, Inc. | 61.05 Million USD | 96.767% |
| TELA Bio, Inc. | 59.16 Million USD | 96.664% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 98.268% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 80.873% |
| Acutus Medical, Inc. | 54.83 Million USD | 96.401% |
| Talis Biomedical Corporation | 29.22 Million USD | 93.246% |
| Spectral AI, Inc. | 12.4 Million USD | 84.084% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 91.468% |
| CVRx, Inc. | 39.28 Million USD | 94.976% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 83.495% |
| PetVivo Holdings, Inc. | 2.42 Million USD | 18.755% |
| Bioventus Inc. | 589.79 Million USD | 99.665% |
| Venus Concept Inc. | 107.1 Million USD | 98.157% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 96.18% |
| LivaNova PLC | 1.15 Billion USD | 99.829% |
| 908 Devices Inc. | 37.49 Million USD | 94.735% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.719% |
| Nemaura Medical Inc. | 26.37 Million USD | 92.518% |
| NeuroPace, Inc. | 86.99 Million USD | 97.731% |
| LENSAR, Inc. | 22.4 Million USD | 91.192% |
| Apyx Medical Corporation | 52.31 Million USD | 96.228% |
| Cutera, Inc. | 518.12 Million USD | 99.619% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 93.27% |
| BioSig Technologies, Inc. | 4.68 Million USD | 57.872% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 96.618% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 90.815% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.91% |
| Axonics, Inc. | 82.35 Million USD | 97.604% |
| Outset Medical, Inc. | 190.91 Million USD | 98.966% |
| IRIDEX Corporation | 24.91 Million USD | 92.078% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 98.408% |
| IRadimed Corporation | 20.73 Million USD | 90.482% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -17.902% |
| INVO Bioscience, Inc. | 19.99 Million USD | 90.129% |
| Telesis Bio, Inc. | 40.87 Million USD | 95.171% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 95.161% |
| Varex Imaging Corporation | 668.6 Million USD | 99.705% |
| Quipt Home Medical Corp. | 136.29 Million USD | 98.552% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 44.746% |
| Pulmonx Corporation | 60.63 Million USD | 96.745% |
| Dynatronics Corporation | 11.78 Million USD | 83.246% |
| Modular Medical, Inc. | 2.27 Million USD | 13.13% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 51.435% |
| Semler Scientific, Inc. | 6.27 Million USD | 68.522% |
| InMode Ltd. | 75.91 Million USD | 97.4% |
| Bruker Corporation | 2.83 Billion USD | 99.93% |
| Cytosorbents Corporation | 29.98 Million USD | 93.418% |
| DexCom, Inc. | 4.19 Billion USD | 99.953% |
| Align Technology, Inc. | 2.45 Billion USD | 99.92% |
| Viveve Medical, Inc. | 10.84 Million USD | 81.804% |
| ZimVie Inc. | 795.85 Million USD | 99.752% |
| Movano Inc. | 5.97 Million USD | 66.951% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 98.113% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -364.089% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 83.495% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.691% |
| Profound Medical Corp. | 12.66 Million USD | 84.417% |
| Insulet Corporation | 1.85 Billion USD | 99.894% |
| enVVeno Medical Corporation | 2.43 Million USD | 18.945% |
| Surmodics, Inc. | 65.82 Million USD | 97.002% |
| iCAD, Inc. | 8 Million USD | 75.332% |
| Nuwellis, Inc. | 6.78 Million USD | 70.89% |
| Biotricity, Inc. | 35.91 Million USD | 94.505% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 99.115% |
| Aethlon Medical, Inc. | 2.47 Million USD | 20.405% |
| InspireMD, Inc. | 8.14 Million USD | 75.759% |
| PAVmed Inc. | 57.13 Million USD | 96.546% |
| BIOLASE, Inc. | 35.34 Million USD | 94.416% |
| Beyond Air, Inc. | 29.77 Million USD | 93.371% |
| FONAR Corporation | 57.45 Million USD | 96.565% |
| AxoGen, Inc. | 101.16 Million USD | 98.049% |
| Vivani Medical, Inc. | 25.03 Million USD | 92.117% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 97.752% |
| Inari Medical, Inc. | 209.32 Million USD | 99.057% |
| UFP Technologies, Inc. | 118.04 Million USD | 98.328% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 84.448% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | 9.705% |
| Tenon Medical, Inc. | 5.56 Million USD | 64.547% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -10.943% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 88.808% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.937% |
| Sintx Technologies, Inc. | 6.59 Million USD | 70.064% |
| NanoVibronix, Inc. | 2.68 Million USD | 26.52% |
| Quanterix Corporation | 78.08 Million USD | 97.472% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 44.746% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 59.597% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.811% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.653% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 88.169% |
| NeuroMetrix, Inc. | 1.33 Million USD | -48.049% |
| Hyperfine, Inc. | 9.8 Million USD | 79.86% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 99.211% |
| Biomerica, Inc. | 2.66 Million USD | 25.885% |
| Bone Biologics Corporation | 831.4 Thousand USD | -137.392% |
| AVITA Medical, Inc. | 19.86 Million USD | 90.065% |
| Silk Road Medical, Inc | 114.15 Million USD | 98.271% |